VITALANT: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization: VITALANT (EIN 86-0098929)
Tax period: 2016-01-01 to 2016-12-31
Filed: 2017-11-13
IRS object ID: 201733179349307498
Schema version: 2016v3.1
Note: A later return for the same period supersedes this one.
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2017-11-13T16:31:35-06:00	ReturnTs
Tax Period End	2016-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	TWO N CENTRAL AVE STE 2300	AddressLine1Txt
City	PHOENIX	CityNm
State Abbreviation	AZ	StateAbbreviationCd
ZIP	85004	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2016-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	860098929	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BLOOD SYSTEMS INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% SUSAN BARNES	InCareOfNm
Business Name Control	BLOO	BusinessNameControlTxt
Phone	4809464201	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	PO BOX 1867	AddressLine1Txt
City	SCOTTSDALE	CityNm
State Abbreviation	AZ	StateAbbreviationCd
ZIP	85252	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	DAVID GREEN	PersonNm
Person Title	PRESIDENT/CEO	PersonTitleTxt
Phone	4809464201	PhoneNum
Signature	2017-11-13	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	PATRICK SHIELDS	PreparerPersonNm
PTIN	P01508556	PTIN
Phone	6023223000	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	68.228.206.89	IPv4AddressTxt

Field	Value	IRS element (for citing)
Federal Original Submission Id	86597020173175000008	FederalOriginalSubmissionId
Federal Original Submission Id	2017-11-13	FederalOriginalSubmissionIdDt
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	75C5EDAB7EBB92AAB100D8D7E73F8E6643DC4F33	AtSubmissionCreationDeviceId
At Submission Filing Device Id	75C5EDAB7EBB92AAB100D8D7E73F8E6643DC4F33	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2016	TaxYr
Build TS	2017-02-10 21:41:12Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	DAVID GREEN	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	SAME AS C ABOVE	AddressLine1Txt
City	SCOTTSDALE	CityNm
State Abbreviation	AZ	StateAbbreviationCd
ZIP	85252	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$710,894,699	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Group Exemption	6167	GroupExemptionNum
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.bloodsystems.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1943	FormationYr
Legal Domicile State	AZ	LegalDomicileStateCd
Activity Or Mission	BLOOD BANKING, PLASMA DERIVATIVE DISTRIBUTION, AND RESEARCH	ActivityOrMissionDesc
Voting Members Governing Body	17	VotingMembersGoverningBodyCnt
Voting Members Independent	17	VotingMembersIndependentCnt
Total Employee	3211	TotalEmployeeCnt
Total Volunteers	920	TotalVolunteersCnt
Total Gross UBI	$202,214,914	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$1,928,782	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$7,622,066	PYContributionsGrantsAmt
CY Contributions Grants	$6,842,379	CYContributionsGrantsAmt
PY Program Service Revenue	$578,648,022	PYProgramServiceRevenueAmt
CY Program Service Revenue	$669,892,181	CYProgramServiceRevenueAmt
PY Investment Income	$48,639,119	PYInvestmentIncomeAmt
CY Investment Income	$5,184,888	CYInvestmentIncomeAmt
PY Other Revenue	$4,991,255	PYOtherRevenueAmt
CY Other Revenue	$524,708	CYOtherRevenueAmt
PY Total Revenue	$639,900,462	PYTotalRevenueAmt
CY Total Revenue	$682,444,156	CYTotalRevenueAmt
PY Grants And Similar Paid	$226,593	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$254,858	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$171,596,686	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$179,910,303	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$437,305,133	PYOtherExpensesAmt
CY Other Expenses	$528,641,025	CYOtherExpensesAmt
PY Total Expenses	$609,128,412	PYTotalExpensesAmt
CY Total Expenses	$708,806,186	CYTotalExpensesAmt
PY Revenues Less Expenses	$30,772,050	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$26,362,030	CYRevenuesLessExpensesAmt
Total Assets BOY	$382,520,351	TotalAssetsBOYAmt
Total Assets EOY	$417,999,357	TotalAssetsEOYAmt
Total Liabilities BOY	$192,026,029	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$221,326,538	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$190,494,322	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$196,672,819	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	Yes (true)	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$281,077,856	ExpenseAmt
Grant	$254,858	GrantAmt
Revenue	$263,080,333	RevenueAmt
Desc	BLOOD CENTER DIVISION - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$365,591,054	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$381,512,652	RevenueAmt
Desc	BIOCARE BIOLOGICALS - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$17,032,252	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$18,038,451	RevenueAmt
Desc	BLOOD SYSTEMS RESEARCH INSTITUTE - SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$7,095,861	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$0	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$7,765,151	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$670,797,023	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	false	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	Yes (true)	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	599	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	3211	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	CJ	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	17	GoverningBodyVotingMembersCnt
Independent Voting Member	17	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (true)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	Yes (true)	LocalChaptersInd
Policies Reference Chapters	Yes (true)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	Yes (true)	InvestmentInJointVentureInd
Written Policy Or Procedure	Yes (true)	WrittenPolicyOrProcedureInd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	SUSAN BARNES	PersonNm
Phone	4806755696	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	6210 E OAK STREET	AddressLine1Txt
City	SCOTTSDALE	CityNm
State Abbreviation	AZ	StateAbbreviationCd
ZIP	85257	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (51 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	OfficerOfficerInd	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
HEATHER J ALLEN MD
TRUSTEE	3.0	0.0	Yes (X)	$24,375	$0	$0
JAMES R ALLEN MD
TRUSTEE (THRU 4/16)	3.0	0.0	Yes (X)	$3,000	$0	$0
LINDA J BLESSING PHD
TRUSTEE	3.0	1.0	Yes (X)	$29,375	$0	$0
ROBERT S COLE
TRUSTEE	2.0	2.0	Yes (X)	$21,500	$0	$0
WILLIAM A DITTMAN MD
TRUSTEE	2.0	1.0	Yes (X)	$19,500	$0	$0
ARMANDO B FLORES
TRUSTEE (THRU 4/16)	4.0	2.0	Yes (X)	$2,000	$0	$0
BILL GATES
TRUSTEE	2.0	1.0	Yes (X)	$21,000	$0	$0
WILLIAM G GREEN
TRUSTEE	2.0	2.0	Yes (X)	$23,500	$0	$0
MICHAEL C JENSEN
TRUSTEE	2.0	1.0	Yes (X)	$19,500	$0	$0
F LEONARD JOHNSON MD
TRUSTEE	2.0	0.0	Yes (X)	$16,000	$0	$0
JOHN S LEWIS
TRUSTEE/CHAIR	3.0	3.0	Yes (X)	$47,250	$0	$0	Yes (X)
PIERRE NOEL MD
TRUSTEE	2.0	0.0	Yes (X)	$21,875	$0	$0
JAMES W PETERSON
TRUSTEE	2.0	1.0	Yes (X)	$19,500	$0	$0
KATHLEEN S PUSHOR
TRUSTEE	3.0	1.0	Yes (X)	$25,875	$0	$0
JIM SCHRAITH
TRUSTEE	2.0	0.0	Yes (X)	$21,500	$0	$0
RICHARD B SPURLOCK MD
TRUSTEE (THRU 4/16)	2.0	2.0	Yes (X)	$0	$0	$0
PAUL E STANDER MD
TRUSTEE	2.0	0.0	Yes (X)	$17,500	$0	$0
RON W WAECKERLIN MD
TRUSTEE/VICE CHAIR	3.0	2.0	Yes (X)	$31,955	$0	$0	Yes (X)
GARY K WILDE
TRUSTEE/SECRETARY/TREASURER	3.0	1.0	Yes (X)	$26,375	$0	$0	Yes (X)
NANCY L WOLLEN
TRUSTEE	2.0	2.0	Yes (X)	$15,000	$0	$0
J Daniel Connor
President/CEO	38.0	2.0		$834,094	$0	$40,083	Yes (X)
Susan Barnes
EXECUTIVE VP/CFO	30.0	20.0		$439,625	$0	$22,214	Yes (X)
David Green
Pres Blood Centers Division	40.0	0.0		$514,557	$0	$31,561	Yes (X)
Bhavi Shah
EVP/General Counsel	30.0	10.0		$312,570	$0	$25,367	Yes (X)
Ralph Vassallo
EVP/Chief Med & Scient OffIcEr	40.0	0.0		$455,195	$0	$17,268	Yes (X)
James Duggar
Division Pres Blood Centers	40.0	0.0		$199,032	$0	$14,001		Yes (X)
Mary Beth Bassett
EVP/Chief Quality Officer	40.0	0.0		$387,875	$0	$35,561		Yes (X)
Michael Busch MD
SVP RESEARCH & SCIENTIFIC PROG	40.0	0.0		$534,773	$0	$39,230		Yes (X)
Tom Choi
VP, Inv Mngmt & Hosp Srvcs	40.0	0.0		$219,750	$0	$13,421		Yes (X)
Vicki Finson
VP, Corporate Integration	40.0	0.0		$235,636	$0	$19,194		Yes (X)
Dennis Harpool
SVP, Operating Systems	40.0	0.0		$239,799	$0	$21,774		Yes (X)
Robert Hartmann
VP, Info Technology	40.0	0.0		$323,094	$0	$22,572		Yes (X)
William Henry
VP, Op MGMT	40.0	0.0		$174,641	$0	$18,248		Yes (X)
Hany Kamel
VP CORPORATE MEDICAL DIRECTOR	40.0	0.0		$411,429	$0	$46,661		Yes (X)
Andrew Kirk
VP, Sales (BioCARE)	40.0	0.0		$316,316	$0	$34,161		Yes (X)
Linda Matthews
President, BioCARE	40.0	0.0		$532,731	$0	$45,525		Yes (X)
Peter Michaelson
VP, Human Resources	40.0	0.0		$323,735	$0	$43,364		Yes (X)
Connie L Morris
VP, Manufacturing & Lab Srvs	40.0	0.0		$190,669	$0	$20,667		Yes (X)
Frank Nizzi
VP, Clinical Services	40.0	0.0		$185,467	$0	$7,859		Yes (X)
Phillip Norris
VP, Research & Scientific Prog	40.0	0.0		$322,674	$0	$42,130		Yes (X)
Jennifer Rataj
VP OF SALES	40.0	0.0		$212,821	$0	$16,119		Yes (X)
Paula Villalobos
VP, Donor Sourcing	40.0	0.0		$237,654	$0	$14,400		Yes (X)
Charles E Wilcox III
SVP, Industry Relations	40.0	0.0		$276,878	$0	$21,375		Yes (X)
Kevin Land
VP, Clinical Services	40.0	0.0		$338,749	$0	$23,416		Yes (X)
Courtney Hopkins
Chief Medical Officer	40.0	0.0		$240,175	$0	$24,325		Yes (X)
Mary Townsend
Sr Medical Director - Corp	40.0	0.0		$295,341	$0	$34,675			Yes (X)
Robin Cusick
Chief Medical Officer	40.0	0.0		$284,646	$0	$29,339			Yes (X)
Paul Eastvold
Chief Medical Officer	40.0	0.0		$274,571	$0	$25,964			Yes (X)
MARISSA LI
MEDICAL DIRECTOR	40.0	0.0		$260,497	$0	$13,050			Yes (X)
LIZABETH MARINARO
MEDICAL DIRECTOR	40.0	0.0		$251,232	$0	$8,542			Yes (X)
SALLY CAGLIOTI
PRESIDENT CTS	0.0	40.0		$0	$520,137	$35,919				Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$10,232,806	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$520,137	TotReportableCompRltdOrgAmt
Total Other Compensation	$807,985	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	199	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (true)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Tolin Mechanical Systems
12005 East 45th Ave	DENVER	CO	80239	Maintenance Service	$1,540,482
MAK Systems
2720 River Rd Suite 225	DES PLAINES	IL	60018	CONSULTANT	$1,504,724
ManPower Inc
21271 Network Place	CHICAGO	IL	90051	CONSULTANT	$1,080,754
Federal Express
PO Box 7221	PASADENA	CA	91109	delivery service	$1,071,651
Synergy Management Consultant
4200 Wisconsin Ave NW Ste 106-10	WASHINGTON	DC	20016	consultant	$575,480

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	39	CntrctRcvdGreaterThan100KCnt
Info In Schedule O Part VIII	Yes (X)	InfoInScheduleOPartVIIIInd
Federated Campaigns	$5,470	FederatedCampaignsAmt
Fundraising	$7,048	FundraisingAmt
Related Organizations	$2,490,533	RelatedOrganizationsAmt
All Other Contributions	$4,339,328	AllOtherContributionsAmt
Noncash Contributions	$4,115,732	NoncashContributionsAmt
Total Contributions	$6,842,379	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
PHARMACEUTICAL SALES	446110	$381,896,586	$179,681,672	$202,214,914
BLOOD AND COMPONENTS SERVICE FEES	541900	$244,891,114	$244,891,114
PLASMA FOR FRACTIONATION	541900	$15,085,525	$15,085,525
LABORATORY SERVICES	621500	$13,519,910	$13,519,910
RESEARCH CONTRACTS	541700	$12,559,690	$12,559,690

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,939,356	TotalRevenueColumnAmt
Related Or Exempt Func Income	$1,939,356	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$669,892,181	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,504,383	TotalRevenueColumnAmt
Exclusion	$2,504,383	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$26,507	TotalRevenueColumnAmt
Exclusion	$26,507	ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$30,997,229	SecuritiesAmt
Other	$124,911	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$28,379,276	SecuritiesAmt
Other	$62,360	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$2,617,953	SecuritiesAmt
Other	$62,551	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,680,505	TotalRevenueColumnAmt
Exclusion	$2,680,505	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$2,702	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$7,048	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$8,907	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$6,205	TotalRevenueColumnAmt
Exclusion	-$6,205	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
MISCELLANEOUS INCOME	900099	$501,180	$501,180
NON-OPERATING MISCELLANEOUS INCOME	900099	$3,226	$3,226

Field	Value	IRS element (for citing)
Other Revenue Total	$504,406	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$682,444,156	TotalRevenueColumnAmt
Related Or Exempt Func Income	$468,181,673	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$202,214,914	UnrelatedBusinessRevenueAmt
Exclusion	$5,205,190	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$254,858	TotalAmt
Program Services	$254,858	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$9,122,182	TotalAmt
Management And General	$9,122,182	ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$126,930,101	TotalAmt
Program Services	$108,918,720	ProgramServicesAmt
Management And General	$18,011,381	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$13,068,690	TotalAmt
Program Services	$9,264,876	ProgramServicesAmt
Management And General	$3,803,814	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$21,569,059	TotalAmt
Program Services	$15,239,115	ProgramServicesAmt
Management And General	$6,329,944	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$9,220,271	TotalAmt
Program Services	$6,498,174	ProgramServicesAmt
Management And General	$2,722,097	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$675,042	TotalAmt
Management And General	$675,042	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$645,808	TotalAmt
Management And General	$645,808	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$152,472	TotalAmt
Management And General	$152,472	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$4,325,489	TotalAmt
Program Services	$1,086,570	ProgramServicesAmt
Management And General	$3,238,919	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$255,154	TotalAmt
Program Services	$255,154	ProgramServicesAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$19,882,007	TotalAmt
Program Services	$14,633,523	ProgramServicesAmt
Management And General	$5,248,484	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$5,624,203	TotalAmt
Program Services	$10,636,599	ProgramServicesAmt
Management And General	-$5,012,396	ManagementAndGeneralAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$12,561,926	TotalAmt
Program Services	$11,037,648	ProgramServicesAmt
Management And General	$1,524,278	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$11,346,615	TotalAmt
Program Services	$9,103,895	ProgramServicesAmt
Management And General	$2,242,720	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$1,795,812	TotalAmt
Program Services	$1,001	ProgramServicesAmt
Management And General	$1,794,811	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$13,042,532	TotalAmt
Program Services	$5,294,258	ProgramServicesAmt
Management And General	$7,748,274	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$2,049,870	TotalAmt
Program Services	$1,692,200	ProgramServicesAmt
Management And General	$357,670	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt
PHARM. PRODUCTS PURCHASED	$359,686,633	$359,686,633
OPERATING & TESTING SUPPLIES	$85,558,998	$85,558,998
DONOR RECOGNITION & PROMO	$9,910,058	$9,910,058
INCOME TAX	$760,933	$760,933

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$367,473	TotalAmt
Program Services	$20,963,810	ProgramServicesAmt
Management And General	-$20,596,337	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$708,806,186	TotalAmt
Program Services	$670,797,023	ProgramServicesAmt
Management And General	$38,009,163	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	-$8,639,484	BOYAmt
EOY	$3,687,928	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$87,351,623	BOYAmt
EOY	$78,511,482	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$122,779,113	BOYAmt
EOY	$140,448,032	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$125,000	BOYAmt
EOY	$97,450	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$5,983,051	BOYAmt
EOY	$5,907,474	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$69,301,188	BOYAmt
EOY	$72,485,205	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$6,527,770	BOYAmt
EOY	$6,653,151	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$225,258,650	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$150,008,300	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$66,114,094	BOYAmt
EOY	$75,250,350	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$25,097,431	BOYAmt
EOY	$27,130,153	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$6,743,105	BOYAmt
EOY	$6,743,105	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$360,000	BOYAmt
EOY	$240,000	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$777,460	BOYAmt
EOY	$845,027	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$382,520,351	BOYAmt
EOY	$417,999,357	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$107,239,610	BOYAmt
EOY	$139,501,909	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$23,620,000	BOYAmt
EOY	$21,265,000	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$16,014,465	BOYAmt
EOY	$12,611,861	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$45,151,954	BOYAmt
EOY	$47,947,768	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$192,026,029	BOYAmt
EOY	$221,326,538	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$190,494,322	BOYAmt
EOY	$196,663,319	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$9,500	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$190,494,322	BOYAmt
EOY	$196,672,819	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$382,520,351	BOYAmt
EOY	$417,999,357	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	-$26,362,030	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$2,743,744	NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts	$798,365	DonatedServicesAndUseFcltsAmt
Other Changes In Net Assets	$28,998,418	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org509a2	Yes (X)	PubliclySupportedOrg509a2Ind

Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$9,272,139	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$8,382,904	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$8,365,565	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$7,622,066	CurrentTaxYearMinus1YearAmt
Current Tax Year	$6,845,081	CurrentTaxYearAmt
Total	$40,487,755	TotalAmt

Gross Receipts Admissions GrossReceiptsAdmissionsGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$483,844,494	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$476,310,348	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$488,608,480	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$411,975,653	CurrentTaxYearMinus1YearAmt
Current Tax Year	$468,181,673	CurrentTaxYearAmt
Total	$2,328,920,648	TotalAmt

Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Tax Rev Levied Orgnztnl Bnft509 TaxRevLeviedOrgnztnlBnft509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl509 GovtFurnSrvcFcltsVl509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total509 Total509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$493,116,633	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$484,693,252	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$496,974,045	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$419,597,719	CurrentTaxYearMinus1YearAmt
Current Tax Year	$475,026,754	CurrentTaxYearAmt
Total	$2,369,408,403	TotalAmt

Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Substantial Contributors Amt SubstantialContributorsAmtGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Public Support Total509	$2,369,408,403	PublicSupportTotal509Amt

Gross Investment Income509 GrossInvestmentIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$3,987,530	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,621,490	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$4,295,796	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,232,549	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,530,890	CurrentTaxYearAmt
Total	$17,668,255	TotalAmt

Post1975 UBTI Post1975UBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$47,343	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$67,686	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$47,439	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$518,513	CurrentTaxYearMinus1YearAmt
Current Tax Year	$1,272,996	CurrentTaxYearAmt
Total	$1,953,977	TotalAmt

Investment Income And UBTI InvestmentIncomeAndUBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$4,034,873	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,689,176	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$4,343,235	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,751,062	CurrentTaxYearMinus1YearAmt
Current Tax Year	$3,803,886	CurrentTaxYearAmt
Total	$19,622,232	TotalAmt

Net Income From Other UBI NetIncomeFromOtherUBIGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Income509 OtherIncome509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Support Calendar Year TotalSupportCalendarYearGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$497,151,506	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$488,382,428	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$501,317,280	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$423,348,781	CurrentTaxYearMinus1YearAmt
Current Tax Year	$478,830,640	CurrentTaxYearAmt
Total	$2,389,030,635	TotalAmt

Field	Value	IRS element (for citing)
Public Support CY509	0.99179	PublicSupportCY509Pct
Public Support PY509	0.99242	PublicSupportPY509Pct
Investment Income CY	0.00821	InvestmentIncomeCYPct
Investment Income PY	0.00758	InvestmentIncomePYPct
Thirty Thr Pct Suprt Tests CY509	Yes (X)	ThirtyThrPctSuprtTestsCY509Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$25,097,431	BeginningYearBalanceAmt
Investment Earnings Or Losses	$2,032,722	InvestmentEarningsOrLossesAmt
End Year Balance	$27,130,153	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$26,960,483	BeginningYearBalanceAmt
Contributions	$483	ContributionsAmt
Investment Earnings Or Losses	-$561,129	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,302,406	OtherExpendituresAmt
End Year Balance	$25,097,431	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$29,650,105	BeginningYearBalanceAmt
Investment Earnings Or Losses	$1,268,538	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,958,160	OtherExpendituresAmt
End Year Balance	$26,960,483	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$27,010,166	BeginningYearBalanceAmt
Investment Earnings Or Losses	$3,712,762	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,072,823	OtherExpendituresAmt
End Year Balance	$29,650,105	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$25,294,973	BeginningYearBalanceAmt
Investment Earnings Or Losses	$2,769,261	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,044,881	OtherExpendituresAmt
Administrative Expenses	$9,187	AdministrativeExpensesAmt
End Year Balance	$27,010,166	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	1.00000	BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$8,679,688	OtherCostOrOtherBasisAmt
Book Value	$8,679,688	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$72,304,313	OtherCostOrOtherBasisAmt
Depreciation	$42,411,166	DepreciationAmt
Book Value	$29,893,147	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$13,594,174	OtherCostOrOtherBasisAmt
Depreciation	$12,420,419	DepreciationAmt
Book Value	$1,173,755	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$76,242,643	OtherCostOrOtherBasisAmt
Depreciation	$62,283,243	DepreciationAmt
Book Value	$13,959,400	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$54,437,832	OtherCostOrOtherBasisAmt
Depreciation	$32,893,472	DepreciationAmt
Book Value	$21,544,360	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$75,250,350	TotalBookValueLandBuildingsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)

DescDesc	AmtAmt
LINE OF CREDIT	$45,000,000
CONTRIBUTIONS PAYABLE	$2,811,122
LONG TERM RENT STEP UP	$135,483
LT TENANT IMPROVEMENT ALLOWANCE	$1,163

Field	Value	IRS element (for citing)
Total Liability	$47,947,768	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE D, PART V, LINE 4

THE BLOOD SYSTEMS BOARD RESTRICTED ENDOWMENT FUNDS ARE RESERVED FOR THE PURPOSES OF PROVIDING RESEARCH FUNDS TO BLOOD SYSTEMS RESEARCH INSTITUTE TO SUPPORT THE BLOOD TRANSFUSION RESEARCH EFFORTS OF THAT DIVISION.

SCHEDULE D, PART X, LINE 2

AT DECEMBER 31, 2016, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2013, THROUGH THE CURRENT TAX YEAR EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2012. AS OF DECEMBER 31, 2016, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2016.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp

Field	Value	IRS element (for citing)
Region	Central America and the Caribbean	RegionTxt
Type Of Activities Conducted	Program Services	TypeOfActivitiesConductedTxt
Specific Services Provided	CAPTIVE INSURANCE	SpecificServicesProvidedTxt
Region Total Expenditures	$4,266,162	RegionTotalExpendituresAmt

Field	Value	IRS element (for citing)
Subtotal Spent	$4,266,162	SubtotalSpentAmt
Total Spent	$4,266,162	TotalSpentAmt
Transfer To Foreign Corp	Yes (true)	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (true)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (6 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
AMERICA'S BLOOD CENTERS
725 15TH STR NW STE 700	WASHINGTON	DC	200052100	866052376	501(C)(6)	$25,000	2016 PLEDGE support
FLIGHTS FOR LIFE
PO BOX 26485	phoenix	AZ	85068	742453899	501(C)(3)	$20,000	donations
MISSION OF MERCY
360 E CORONADO RD	phoenix	AZ	85004	841087689	501(C)(3)	$15,000	donations
HONORHEALTH
8125 N HAYDEN	scottsdale	AZ	85258	742355411	501(C)(3)	$8,000	GOLF BALL SPONSORSHIP
JEWISH FAMILY & CHILDRENS SERVICE
4747 7TH ST suite 100	PHOENIX	AZ	85014	860096781	501(C)(3)	$7,000	BRIGHTER TOMORROW LUNCHEON PLEDGE
FOUNDATION FOR BLIND CHILDREN
1234 E NORTHERN AVE	phoenix	AZ	85002	860129981	501(C)(3)	$6,000	SPONSORSHIP NIGHT FOR SIGHT

Field	Value	IRS element (for citing)
Total501c3 Org	5	Total501c3OrgCnt
Total Other Org	1	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE I, PART I, LINE 2	FormAndLineReferenceDesc
Explanation	SPONSORSHIPS AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (true)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (33 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
J Daniel Connor
President/CEO	$699,339	$0	$123,505	$0	$11,250	$0	$28,600	$0	$11,483	$0	$874,177	$0	$0	$0
Susan Barnes
EXECUTIVE VP/CFO	$344,201	$0	$56,235	$0	$39,189	$0	$10,600	$0	$11,614	$0	$461,839	$0	$28,901	$0
James Duggar
Division Pres Blood Centers	$193,016	$0	$2,693	$0	$3,323	$0	$4,269	$0	$9,732	$0	$213,033	$0	$0	$0
David Green
Pres Blood Centers Division	$393,160	$0	$111,109	$0	$10,288	$0	$16,152	$0	$15,409	$0	$546,118	$0	$0	$0
Bhavi Shah
EVP/General Counsel	$261,118	$0	$41,163	$0	$10,289	$0	$10,600	$0	$14,767	$0	$337,937	$0	$0	$0
Ralph Vassallo
EVP/Chief Med & Scient OffIcEr	$376,642	$0	$68,265	$0	$10,288	$0	$10,472	$0	$6,796	$0	$472,463	$0	$0	$0
Mary Beth Bassett
EVP/Chief Quality Officer	$304,130	$0	$50,970	$0	$32,775	$0	$28,600	$0	$6,961	$0	$423,436	$0	$22,487	$0
Michael Busch MD
SVP RESEARCH & SCIENTIFIC PROG	$428,097	$0	$70,079	$0	$36,597	$0	$28,600	$0	$10,630	$0	$574,003	$0	$27,367	$0
Tom Choi
VP, Inv Mngmt & Hosp Srvcs	$201,181	$0	$9,338	$0	$9,231	$0	$6,580	$0	$6,841	$0	$233,171	$0	$0	$0
Vicki Finson
VP, Corporate Integration	$216,357	$0	$10,048	$0	$9,231	$0	$8,067	$0	$11,127	$0	$254,830	$0	$0	$0
Dennis Harpool
SVP, Operating Systems	$220,467	$0	$10,101	$0	$9,231	$0	$3,797	$0	$17,977	$0	$261,573	$0	$0	$0
Robert Hartmann
VP, Info Technology	$218,008	$0	$42,748	$0	$62,338	$0	$10,600	$0	$11,972	$0	$345,666	$0	$0	$0
William Henry
VP, Op MGMT	$164,308	$0	$3,121	$0	$7,212	$0	$4,036	$0	$14,212	$0	$192,889	$0	$0	$0
Hany Kamel
VP CORPORATE MEDICAL DIRECTOR	$331,328	$0	$56,644	$0	$23,457	$0	$28,600	$0	$18,061	$0	$458,090	$0	$14,226	$0
Andrew Kirk
VP, Sales (BioCARE)	$175,078	$0	$132,007	$0	$9,231	$0	$7,585	$0	$26,576	$0	$350,477	$0	$0	$0
Linda Matthews
President, BioCARE	$304,674	$0	$185,463	$0	$42,594	$0	$28,600	$0	$16,925	$0	$578,256	$0	$32,305	$0
Peter Michaelson
VP, Human Resources	$266,150	$0	$48,354	$0	$9,231	$0	$28,600	$0	$14,764	$0	$367,099	$0	$0	$0
Connie L Morris
VP, Manufacturing & Lab Srvs	$172,956	$0	$8,482	$0	$9,231	$0	$6,106	$0	$14,561	$0	$211,336	$0	$0	$0
Frank Nizzi
VP, Clinical Services	$125,327	$0	$57,925	$0	$2,215	$0	$5,098	$0	$2,761	$0	$193,326	$0	$0	$0
Phillip Norris
VP, Research & Scientific Prog	$273,125	$0	$49,549	$0	$0	$0	$28,357	$0	$13,773	$0	$364,804	$0	$0	$0
Jennifer Rataj
VP OF SALES	$166,492	$0	$38,310	$0	$8,019	$0	$0	$0	$16,119	$0	$228,940	$0	$0	$0
Paula Villalobos
VP, Donor Sourcing	$218,323	$0	$10,100	$0	$9,231	$0	$6,141	$0	$8,259	$0	$252,054	$0	$0	$0
Charles E Wilcox III
SVP, Industry Relations	$255,202	$0	$12,445	$0	$9,231	$0	$10,600	$0	$10,775	$0	$298,253	$0	$0	$0
Kevin Land
VP, Clinical Services	$320,520	$0	$18,229	$0	$0	$0	$8,609	$0	$14,807	$0	$362,165	$0	$0	$0
Mary Townsend
Sr Medical Director - Corp	$279,496	$0	$15,845	$0	$0	$0	$10,600	$0	$24,075	$0	$330,016	$0	$0	$0
Robin Cusick
Chief Medical Officer	$269,321	$0	$15,325	$0	$0	$0	$28,103	$0	$1,236	$0	$313,985	$0	$0	$0
Paul Eastvold
Chief Medical Officer	$259,866	$0	$14,705	$0	$0	$0	$8,588	$0	$17,376	$0	$300,535	$0	$0	$0
Courtney Hopkins
Chief Medical Officer	$240,175	$0	$0	$0	$0	$0	$7,357	$0	$16,968	$0	$264,500	$0	$0	$0
MARISSA LI
MEDICAL DIRECTOR	$246,470	$0	$14,027	$0	$0	$0	$7,360	$0	$5,690	$0	$273,547	$0	$0	$0
LIZABETH MARINARO
MEDICAL DIRECTOR	$237,702	$0	$13,530	$0	$0	$0	$7,331	$0	$1,211	$0	$259,774	$0	$0	$0
BRIAN CUSTER
ASSOCIATE DIRECTOR	$225,347	$0	$9,735	$0	$0	$0	$4,397	$0	$6,519	$0	$245,998	$0	$0	$0
AUDREY JENNINGS
DIRECTOR, DISTRICT FIELD OPS	$166,822	$0	$3,633	$0	$57,858	$0	$6,947	$0	$8,580	$0	$243,840	$0	$0	$0
SALLY CAGLIOTI
PRESIDENT CTS	$0	$399,608	$0	$110,241	$0	$10,288	$0	$28,600	$0	$7,319	$0	$556,056	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE J, PART I, LINE 4a	CERTAIN EMPLOYEES RECEIVED SEVERANCE PAYMENTS DURING 2016 AS FOLLOWS: ROBERT HARTMANN - $54,954 AUDREY JENNINGS - $53,704 THESE AMOUNTS ARE TAXABLE AND ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2016 AS FOLLOWS: MARY BETH BASSETT: $22,487 (RESULTING FROM ALMOST 21 YEARS OF SERVICE) MICHAEL BUSCH, MD: $27,367 (RESULTING FROM ALMOST 18 YEARS OF SERVICE) HANY KAMEL, MD: $14,226 (RESULTING FROM ALMOST 21 YEARS OF SERVICE) LINDA MATTHEWS: $32,305 (RESULTING FROM ALMOST 17 YEARS OF SERVICE) SUSAN L. BARNES: $28,901 (RESULTING FROM ALMOST 27 YEARS OF SERVICE) THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN B(III) AND ALSO IN COLUMN (F) SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011.
SCHEDULE J, PART I, LINE 7	BLOOD SYSTEMS HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES.
SCHEDULE J, PART II	DAVID GREEN RECEIVED A RETENTION BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). LINDA MATTHEWS IS THE PRESIDENT OF THE BIOCARE DIVISION OF BLOOD SYSTEMS. THIS DIVISION PERFORMED WELL ABOVE ITS BUDGETED EXPECTATION AND WAS GRANTED AN INCENTIVE BONUS UNDER THE COMPANY'S PLAN. ANDREW KIRK, VP OF SALES FOR BIOCARE, ALSO RECEIVED A SALES PERFORMANCE AWARD.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	ARIZONA HEALTH FACILITIES AUTHORITY	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	860453292	BondIssuerEIN
Bond Issued	2014-01-06	BondIssuedDt
Issue Price	$27,005,000	IssuePriceAmt
Purpose	SEE PART VI	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$5,740,000	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$27,005,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$41,114	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$26,963,886	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2014	SubstantialCompletionYr
Current Refunding	Yes (true)	CurrentRefundingInd
Advance Refunding	false	AdvanceRefundingInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	false	MgmtContractBondFincdPropInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	false	EngageBondCounselResearchInd
Private Bus Use By Others	0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.00700	PrivateBusConcerningUBIPct
Total Private Business Use	0.00700	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Exception To Rebate	Yes (true)	ExceptionToRebateInd
Variable Rate Issue	false	VariableRateIssueInd
Hedge Identified In Bks And Rec	false	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	.	FormAndLineReferenceDesc
Explanation	Schedule K, Part I, Line A, Column (F) REFUNDING OF AHFA 2004 BOND ISSUE WHICH WAS USED FOR THE PURCHASE OF LAND AND TO CONSTRUCT AND EQUIP 11 BLOOD CENTERS IN VARIOUS STATES FOR THE PURPOSE OF RECRUITING, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD PRODUCTS; REFUNDING OF ABAG 2002 BOND ISSUE USED TO CONSTRUCT A BLOOD CENTER IN SAN FRANCISCO, CA; AND, REFUNDING OF AHFA 1995 VARIABLE RATE BOND ISSUE USED TO CONSTRUCT AND EQUIP A NATIONAL BLOOD TESTING LABORATORY IN TEMPE, ARIZONA.	ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp

Field	Value	IRS element (for citing)
Person	DAVID GREEN	PersonNm
Relationship With Org	officer	RelationshipWithOrgTxt
Loan Purpose	HOUSE	LoanPurposeTxt
Loan From Organization	Yes (X)	LoanFromOrganizationInd
Original Principal	$150,000	OriginalPrincipalAmt
Balance Due	$97,450	BalanceDueAmt
Default	false	DefaultInd
Board Or Committee Approval	Yes (true)	BoardOrCommitteeApprovalInd
Written Agreement	Yes (true)	WrittenAgreementInd

Field	Value	IRS element (for citing)
Total Balance Due	$97,450	TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp
Clothing And Household Goods		ClothingAndHouseholdGoodsGrp
Cars And Other Vehicles		CarsAndOtherVehiclesGrp
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp
Securities Publicly Traded		SecuritiesPubliclyTradedGrp
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp
Food Inventory		FoodInventoryGrp
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	RECOGNITION	263	$4,092,751	COST/SELLING PRICE
Yes (X)	REFRESHMENT	39	$19,680	COST/SELLING PRICE
Yes (X)	OTHER	16	$3,301	COST/SELLING PRICE

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE M, PART I, COLUMN (B)	FormAndLineReferenceDesc
Explanation	THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED IN COLUMN (B).	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART III, LINE 1	THE MISSION OF BLOOD SYSTEMS, INC. ("BSI") IS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. TO FURTHER ITS MISSION, BSI OPERATES COMMUNITY BLOOD CENTERS. THESE CENTERS RECRUIT BLOOD DONORS AND COLLECT, PROCESS AND DISTRIBUTE APPROXIMATELY 905,000 BLOOD COLLECTIONS TO MEET THE BLOOD NEEDS OF PATIENTS IN MORE THAN 500 HOSPITALS THROUGHOUT THE COUNTRY. THE STAFF SERVES A GEOGRAPHIC AREA COVERING THE UNITED STATES, FROM THE EAST COAST TO CALIFORNIA AND FROM THE CANADIAN BORDER TO MEXICO. BSI IS LICENSED BY THE U.S. FOOD AND DRUG ADMINISTRATION ("FDA") AS A PROVIDER OF BLOOD AND BLOOD SERVICES. THE COMPANY'S THREE OPERATING DIVISIONS ARE: (1) BLOOD SERVICES DIVISION, WHICH INCLUDES UNITED BLOOD SERVICES; (2) THE BIOCARE DIVISION; AND (3) THE BLOOD SYSTEMS RESEARCH INSTITUTE. THESE OPERATING DIVISIONS ARE UNINCORPORATED DIVISIONS DOING BUSINESS UNDER REGISTERED TRADENAMES AND SERVICE MARKS. BSI CONDUCTS ITS BLOOD BANKING ACTIVITIES THROUGH ITS REGIONAL BLOOD CENTERS LOCATED IN THE FOLLOWING STATES: ARIZONA, CALIFORNIA, COLORADO, LOUISIANA, MISSISSIPPI, MONTANA, NEVADA, NEW MEXICO, NORTH DAKOTA, SOUTH DAKOTA, TENNESSEE, TEXAS, OHIO, NEW JERSEY, WASHINGTON AND WYOMING. THE BIOCARE DIVISION DISTRIBUTES PLASMA-DERIVED PRODUCTS THROUGH HOSPITALS, COMMUNITY BLOOD CENTER LOCATIONS AND ALSO DIRECTLY FROM ITS HEADQUARTERS IN TEMPE, ARIZONA. BLOOD-RELATED RESEARCH IS CONDUCTED AT THE BLOOD SYSTEMS RESEARCH INSTITUTE LOCATED IN SAN FRANCISCO, CALIFORNIA. FORM 990, PART III, LINE 2 EFFECTIVE JANUARY 1, 2017 BLOODSOURCE, INC. MERGED INTO BSI. BSI IS THE SURVIVING ENITY. BLOODSOURCE, INC. CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF BSI. EFFECTIVE JANUARY 1, 2017 BELLE BONFILS MEMORIAL BLOOD CENTER ("BBMBC") MERGED INTO BSI. BSI IS THE SURVIVING ENITY. BBMBC CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF BSI. EFFECTIVE NOVEMBER 27, 2016 INLAND NORTHWEST BLOOD CENTER ("INBC") MERGED INTO BSI. BSI IS THE SURVIVING ENITY. INBC CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF BSI. EFFECTIVE JUNE 30, 2016 MID-SOUTH REGIONAL BLOOD CENTER INC (DBA LIFEBLOOD) MERGED INTO BSI. BSI IS THE SURVIVING ENITY. LIFEBLOOD CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF BSI. EFFECTIVE JUNE 30, 2016 LIFESHARE COMMUNITY BLOOD SERVICES ("LCBS") MERGED INTO BSI. BSI IS THE SURVIVING ENITY. LCBS CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF BSI.
FORM 990, PART III, LINES 4A-D	4A) BLOOD SERVICES - BLOOD BANKING THE PRIMARY PURPOSE OF BLOOD SERVVICES DIVISION (BSD) IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF BSD IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. BSD COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELLS, PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 4B) BIOCARE - BIOLOGICALS THE BIOCARE DIVISION PROVIDES BIOLOGICAL PRODUCTS, BOTH HUMAN-PLASMA DERIVED AND RECOMBINANT PRODUCTS, THAT SERVE AS ADJUNCT THERAPIES IN TRANSFUSION MEDICINE AND HEALTHCARE. PLASMA DERIVATIVES ARE BASICALLY PROTEIN THERAPIES PROVIDED FROM PLASMA LEFT OVER FROM WHOLE BLOOD DONATIONS. EXAMPLES OF SUCH PLASMA DERIVATIVES INCLUDE: INTRAVENOUS IMMUNE GLOBULINS, COAGULATION FACTORS, ALBUMIN AND FIBRIN SEALANTS. THESE PRODUCTS ARE USED AS THERAPIES FOR IMMUNE SYSTEM DISORDERS, BLEEDING DISORDERS AND WOUND MANAGEMENT. RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. RECOMBINANT-BASED PRODUCTS ARE OFTEN STABILIZED WITH ALBUMIN (CONCENTRATE OF PLASMA PROTEINS FROM HUMAN PLASMA), BUT THESE PRODUCTS ARE NOT MANUFACTURED FROM HUMAN PLASMA. THESE RECOMBINANT PRODUCTS, SIMILAR TO THE PLASMA-DERIVATIVE PRODUCTS, ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. 4C) BLOOD SYSTEMS RESEARCH INSTITUTE BLOOD SYSTEMS RESEARCH INSTITUTE ("BSRI") FACILITATES RESEARCH PRIMARILY FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHERS). THE RESEARCH IS IN TRANSFUSION MEDICINE EPIDEMIOLOGY, HEALTH POLICY, VIROLOGY, VIRAL DISCOVERY, THE IMMUNE REACTION TO TRANSFUSION AND TO TRANSFUSION-TRANSMITTED INFECTIOUS AGENTS, CELL THERAPY AND GENETIC EPIDEMIOLOGY. AREAS STUDIED INCLUDE IMPLICATIONS OF RECEIVING COMPONENTS AT DIFFERENT STORAGE AGES; MECHANISM OF VIRUS ENTRY INTO CELLS; HOW TRANSFUSION TRANSMITTED VIRUSES CAUSE SYMPTOMS; THE USE OF COMMERCIALLY AVAILABLE OR LOCALLY-DEVELOPED DONOR TESTS; THE FACTORS LEADING TO CHIMERISM, ETC. BSRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF EPIDEMIOLOGY RESEARCH SCIENTISTS. BSRI INVESTIGATORS PUBLISH MORE THAN 60 PAPERS EACH YEAR IN THE PEER-REVIEWED SCIENTIFIC LITERATURE. THE RESEARCH FACILITY IS STAFFED WITH 10 INVESTIGATORS, 21 RESEARCH ASSOCIATES, 12 STAFF SCIENTISTS AND VARIOUS OTHER POSITIONS AS WELL AS ADMINISTRATIVE SUPPORT. 4D) OTHER PROGRAM SERVICES CONSIST OF LABORATORY SERVICES AND OTHER PROGRAM ACTIVITIES.
FORM 990, PART VI, LINE 1A	THE EXECUTIVE COMMITTEE HAS THE POWERS OF THE BOARD OF TRUSTEES BETWEEN BOARD MEETINGS, UNLESS PROHIBITED BY LAW OR THE ARTICLES OF INCORPORATION. THE EXECUTIVE COMMITTEE IS COMPOSED OF 6 OR MORE TRUSTEES, INCLUDING THE CHAIR, VICE CHAIR, SECRETARY-TREASURER, AND THREE OR MORE TRUSTEES SELECTED BY THE BOARD OF TRUSTEES. FORM 990, PART VI, LINE 4 THE BYLAWS OF BLOOD SYSTEMS, INC. WERE AMENDED IN 2016 TO REMOVE BLOOD CENTERS OF THE PACIFIC ("BCP") AS AN AFFILIATE, DUE TO THE MERGER OF BCP INTO BSI, EFFECTIVE JANUARY 1, 2016.
FORM 990, PART VI, LINE 11B	THE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE COMMITTEES AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, LINE 12C	EACH YEAR, THE BOARD OF TRUSTEES AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE TRUSTEES, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990.
FORM 990, PART VI, LINES 15A AND 15B	THE BOARD OF TRUSTEES HAS A COMPENSATION AND HUMAN RESOURCE COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO AND OTHER OFFICERS OF THE CORPORATION. THE MEMBERS OF THE HUMAN RESOURCE AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE MINUTES OF THE BOARD MEETINGS. THIS PROCESS WAS LAST COMPLETED IN 2016.
FORM 990, PART VI, LINE 19	THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE ORGANIZATION'S WEBSITE.
FORM 990, PART VII	IN 2012, SALLY CAGLIOTI WAS REPORTED AS AN OFFICER OF BLOOD SYSTEMS, INC. ("BSI"). CREATIVE TESTING SOLUTIONS ("CTS"), A RELATED 501(C)(3) ORGANIZATION, LEASED THEIR EMPLOYEES FROM BSI IN 2012, INCLUDING SALLY CAGLIOTI. IN 2013 CTS HIRED THEIR OWN EMPLOYEES, INCLUDING SALLY CAGLIOTI THUS, SHE IS NO LONGER CONSIDERED AN OFFICER OR KEY EMPLOYEE OF BSI. FOR THIS REASON, SALLY CAGLIOTI IS BEING REPORTED AS FORMER.
FORM 990, PART VIII, LINE 2A	AS DESCRIBED IN THE NARRATIVE FOR PART III, LINE 4B, BIOCARE IS A DIVISION OF BLOOD SYSTEMS INC. THE BIOCARE DIVISION WAS CONCEIVED TO PROVIDE BLOOD BANK REAGENTS AND TRANSFUSION MEDICINE-RELATED, PLASMA-DERIVED PHARMACEUTICAL DERIVATIVES TO EXISTING HOSPITAL CUSTOMERS AS A CONVENIENT, VALUE-ADDED SERVICE. CURRENTLY, BIOCARE FUNCTIONS AS A SPECIALTY DISTRIBUTOR OF THERAPEUTIC PLASMA-DERIVATIVE PRODUCTS AND, INCREASINGLY, RECOMBINANT-BASED PRODUCTS TO BLOOD SYSTEMS TRADITIONAL CUSTOMER BASE OF HOSPITALS, AS WELL AS OUT-PATIENT SURGERY CENTERS, SPECIALTY PHARMACIES AND PHYSICIAN PRACTICES. THE MAJORITY OF PRODUCTS SOLD ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. ALL OF THE PRODUCTS SOLD BY BIOCARE ARE MANUFACTURED BY COMMERCIAL BIO-PHARMACEUTICAL COMPANIES. THE SIGNIFICANT DIFFERENCE BETWEEN BIOCARE AND ITS FOR-PROFIT COMPETITORS IN TERMS OF PRICING IS THAT IN THE EVENT THERE IS A SHORTAGE OF CERTAIN PRODUCT, THE FOR-PROFIT COMPETITORS MAY RAISE THEIR PRICING UP TO TWO OR THREE TIMES NORMAL PRICING, WHILE BIOCARE MAINTAINS ITS PRICING VERY CLOSE TO ORIGINAL LEVELS, ONLY INCREASING PRICING TO OFFSET INCREASED ACQUISITION COSTS. THE REASON BIOCARE HAS TAKEN THIS APPROACH IS DUE TO BSIS EXEMPT PURPOSE TO DELIVER PRODUCTS FOR TRANSFUSION AND TREATMENT PURPOSES. BIOCARE ALSO DIFFERS FROM ITS FOR-PROFIT COMPETITORS IN THAT BIOCARES DISTRIBUTION SERVICES OFFER SAME-DAY AND STAT DELIVERY OPTIONS OVER THE WEEKEND OR AFTER HOURS FOR A MUCH LOWER COST THAN ITS FOR-PROFIT COMPETITORS. BIOCARE REPRESENTS THE FASTEST POSSIBLE OPTION OF GETTING LIFE-SAVING PLASMA-DERIVED AND RECOMBINANT-BASED PRODUCTS TO ITS TRADITIONAL CUSTOMER BASE OVER THE WEEKEND (FRIDAY, SATURDAY AND SUNDAY). MOST FOR-PROFIT COMPETITORS DO PROVIDE 24 HOUR ORDERING SERVICES; HOWEVER, UNLESS AN ORDER IS RECEIVED PRIOR TO THE CLOSE OF BUSINESS ON THURSDAY, THE PRODUCT WILL NOT BE DELIVERED UNTIL THE FOLLOWING WEEK. BIOCARE ALSO USES APPROXIMATELY 20 ORDERING LOCATIONS (FACILITIES) NATIONWIDE THAT ARE CAPABLE OF STORING AND DISTRIBUTING PRODUCT, WHILE MOST COMPETITORS ONLY HAVE A FEW. IT SHOULD BE NOTED THAT THE ACTIVITIES UNDERTAKEN BY BLOOD SYSTEMS RELATED TO ITS EXEMPT PURPOSES AS A WHOLE ARE SUBSTANTIAL AS COMPARED TO THE ACTIVITIES OF THE BIOCARE DIVISION. WHILE BIOCARE COMPRISES A SIGNIFICANT PORTION OF BSIS OVERALL REVENUE, THE NUMBER OF EMPLOYEES (APPROXIMATELY 43) AND HOURS PRODUCING THIS REVENUE IS VERY SMALL, AS COMPARED TO THE TOTAL NUMBER OF BSI EMPLOYEES (APPROXMATELY 3,200) AND HOURS PRODUCING THE RELATED EXEMPT PURPOSE REVENUE. PLASMA-DERIVATIVE PRODUCTS TREATED AS RELATED (COL B) - PLASMA-DERIVATIVE PRODUCTS ARE PRODUCTS THAT ARE MANUFACTURED FROM PROTEINS FOUND IN HUMAN PLASMA AND ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD BORNE MEDICAL CONDITIONS. IT IS BLOOD SYSTEMS POSITION THAT PROVIDING BLOOD-DERIVED PRODUCTS, WHICH ARE MANUFACTURED BY BIO-PHARMACEUTICAL COMPANIES USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS FOR USE IN TREATING MEDICAL CONDITIONS OF PATIENTS IS DIRECTLY RELATED TO BLOOD SYSTEMS EXEMPT PURPOSES. AS THE PRODUCTS SOLD ARE MADE FROM AND CONTAIN HUMAN BLOOD/PLASMA AND PROTEIN, THERE IS A SUBSTANTIAL NEXUS BETWEEN THE SALE OF THESE PRODUCTS AND BLOOD SYSTEMS EXEMPT PURPOSES. IT SHOULD BE NOTED THAT OTHER NON-PROFIT COMPETITORS ALSO TREAT SIMILAR REVENUE AS RELATED, THUS MAKING IT AN INDUSTRY STANDARD. ACCORDINGLY, THE SALE OF PLASMA-DERIVATIVE PRODUCTS IS BEING TREATED AS RELATED REVENUE (SEE PART VIII, LINE 2A, COLUMN (B)). RECOMBINANT-BASED PRODUCTS TREATED AS UNRELATED (COL C) - RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. IT IS BSIS POSITION THAT THE PROVISION OF RECOMBINANT-BASED DRUG PRODUCTS, WHICH ARE MANUFACTURED THROUGH GENETIC ENGINEERING BY BIO-PHARMACEUTICAL COMPANIES NOT USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS USED TO TREAT MEDICAL CONDITIONS IS NOT DIRECTLY RELATED TO BLOOD SYSTEMS PURPOSES. ACCORDINGLY, THE SALE OF RECOMBINANT-BASED PRODUCTS IS BEING TREATED AS UNRELATED BUSINESS INCOME (SEE PART VIII, LINE 2A, COLUMN (C)). DUE TO THE GROWTH IN AND EXPANSION OF THE BIOCARE DIVISION, AND THE POSITION RECENTLY TAKEN TO TREAT RECOMBINANT PRODUCTS AS UNRELATED BUSINESS INCOME, BLOOD SYSTEMS INC. FORMED BIOCARE, INC., AN ARIZONA FOR-PROFIT C CORPORATION EFFECTIVE SEPTEMBER 15, 2016. THE BIOCARE DIVISION OF BLOOD SYSTEMS, INC., IN ITS ENTIRETY, WILL BE TRANSFERRED TO AND OPERATED BY BIOCARE, INC. EFFECTIVE JANUARY 1, 2017.
FORM 990, PART XI, LINE 9	RECLASSIFICATION/DECONSOLIDATION $ 129,500 MERGER OF NET ASSETS $ 30,939,578 PENSION RECAPTURE EXP OTHER THAN NET PERIODIC COST $ (2,070,661) ------------- TOTAL $ 28,998,418

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (9 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
CREATIVE TESTING SOLUTIONS
6210 EAST OAK STREET	SCOTTDALE	AZ	85257	271120123	SAFETY TEST.	AZ	501(C)(3)	11	BSI	Yes (true)
BLOODSOURCE INC
10536 PETER A MCCUEN BLVD	MATHER	CA	95655	941231001	BLOOD BANKING	CA	501(C)(3)	10	BSI	Yes (true)
INLAND NORTHWEST BLOOD CENTER
210 W CATALDO AVENUE	SPOKANE	WA	99201	910499130	BLOOD BANKING	WA	501(C)(3)	10	BSI	Yes (true)
BLOOD CENTER FND OF THE INLAND NORTHWEST
210 W CATALDO AVENUE	SPOKANE	WA	99201	464347438	FUNDRAISING	WA	501(C)(3)	7	INBC	Yes (true)
BELLE BONFILS MEMORIAL BLOOD CENTER
717 YOSEMITE STREET	DENVER	CO	80230	840411209	BLOOD BANKING	CO	501(C)(3)	10	BSI	Yes (true)
BONFILS BLOOD CENTER FOUNDATION
717 YOSEMITE STREET	DENVER	CO	80230	742787586	FUNDRAISING	CO	501(C)(3)	7	BBMBC	Yes (true)
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
PO BOX 1429	SAN BERNARDINO	CA	92402	951708743	BLOOD BANKING	CA	501(C)(3)	10	BSI	Yes (true)
BLOOD BANK SAN BERNARDINORIVERSIDE FDN
PO BOX 1429	SAN BERNARDINO	CA	92402	208911074	FUNDRAISING	CA	501(C)(3)	12-TYPE I	BBSBRC	Yes (true)
MID-SOUTH REGIONAL BLOOD CENTER INC
1040 MADISON AVENUE	MEMPHIS	TN	38104	620719021	BLOOD BANKING	TN	501(C)(3)	10	BSI	Yes (true)

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (3 entries)

Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Entity TypeEntityTypeTxt	Share Of Total IncomeShareOfTotalIncomeAmt	Share Of EOY AssetsShareOfEOYAssetsAmt	OwnershipOwnershipPct	Controlled OrganizationControlledOrganizationInd	Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Legal Domicile StateLegalDomicileStateCd
CANYON STATE INSURANCE COMPANY
WEST BAY ROAD	GRAND CAYMAN	CJ	981084327	INVESTMENT	CJ	BSI	FOREIGN	$4,775,929	$30,280,954	1.00000	Yes (true)
BIOCARE INC
			813906720	PHARMA		BSI	C CORP	$0	$0	1.00000	Yes (true)	6210 E OAK ST	SCOTTSDALE	AZ	85257	AZ
TRANSFUSION TECHNOLOGY INC
			223494865	INACTIVE		BCRBC	C CORP				Yes (true)	102 CHESTNUT RIDGE ROAD	MONTVALE	NJ	07645	NJ

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	Yes (true)	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	Yes (true)	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	Yes (true)	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (true)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	Yes (true)	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (true)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	Yes (true)	TransferToOtherOrgInd
Transfer From Other Org	Yes (true)	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (42 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
BLOODSOURCE INC
C	$799,114	ACCRUAL
BLOODSOURCE INC
G	$11,591,307	ACCRUAL
BLOODSOURCE INC
H	$4,838,554	ACCRUAL
BLOODSOURCE INC
K	$1,698,816	ACCRUAL
BLOODSOURCE INC
L	$3,567,000	ACCRUAL
BLOODSOURCE INC
Q	$594,679	ACCRUAL
BLOODSOURCE INC
S	$72,575	ACCRUAL
CANYON STATE INSURANCE COMPANY
R	$4,266,162	ACCRUAL
CREATIVE TESTING SOLUTIONS
M	$33,005,393	ACCRUAL
CREATIVE TESTING SOLUTIONS
L	$4,945,547	ACCRUAL
CREATIVE TESTING SOLUTIONS
A	$1,060,080	ACCRUAL
CREATIVE TESTING SOLUTIONS
C	$1,177,328	ACCRUAL
CREATIVE TESTING SOLUTIONS
Q	$351,860	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
G	$815,639	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
H	$2,161,167	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
L	$1,320,504	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
M	$76,892	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
Q	$264,183	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
C	$102,919	ACCRUAL
BELLE BONFILS MEMORIAL BLOOD CENTER
K	$107,919	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
G	$8,250,526	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
H	$1,151,324	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
L	$1,318,993	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
Q	$272,903	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
G	$856,940	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
H	$134,760	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
L	$444,174	ACCRUAL
BLOOD BANK OF SAN BERNARDINO & RIVERSIDE
C	$53,297	ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
G	$1,222,321	ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
H	$412,155	ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
L	$734,447	ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
Q	$170,246	ACCRUAL
BERGEN COMMUNITY REGIONAL BLOOD CENTER
C	$206,913	ACCRUAL
MID-SOUTH REGIONAL BLOOD CENTER INC
G	$1,869,422	ACCRUAL
MID-SOUTH REGIONAL BLOOD CENTER INC
H	$335,200	ACCRUAL
MID-SOUTH REGIONAL BLOOD CENTER INC
L	$306,179	ACCRUAL
MID-SOUTH REGIONAL BLOOD CENTER INC
C	$74,844	ACCRUAL
INLAND NORTHWEST BLOOD CENTER
H	$665,435	ACCRUAL
INLAND NORTHWEST BLOOD CENTER
L	$1,448,464	ACCRUAL
INLAND NORTHWEST BLOOD CENTER
Q	$111,938	ACCRUAL
INLAND NORTHWEST BLOOD CENTER
P	$137,500	ACCRUAL
INLAND NORTHWEST BLOOD CENTER
C	$76,118	ACCRUAL